Zytiga: Medgend

Zytiga FDA Approved Drugs

ZYTIGA [Abiraterone Acetate^{C₂₆H₃₃NO₂}]

250mg (oral tablet)

500mg (oral tablet)

Janssen Biotech^{Apr 28, 2011}

Use in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer who had received prior docetaxel chemotherapy.
Use in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer who have received prior chemotherapy containing docetaxel.
Use in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.